ArticleThe Journal of pharmacology and experimental therapeutics2011

Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.

Haoming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.